Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
F. Lindmark, S. L. Zheng, F. Wiklund, K. A. Bälter, J. Sun, B. Chang, M. Hedelin, J. Clark, J. E. Johansson, D. A. Meyers, H. O. Adami, W. Isaacs, H. Grönberg, J. Xu
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk'. Together they form a unique fingerprint.